Stock data
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX) reported net income of -US$36.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$39.70M | -US$36.12M | — |
| 2024 | — | — | -US$29.92M | -US$26.73M | — |
| 2023 | — | — | -US$25.07M | -US$23.96M | — |
| 2022 | — | — | -US$15.38M | -US$14.84M | — |
| 2021 | — | — | -US$10.53M | -US$10.46M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$14.56M | — |
| 2026-03-31 | — | -US$8.68M | — |
| 2025-12-31 | — | -US$13.03M | — |
| 2025-09-30 | — | -US$9.69M | — |
| 2025-06-30 | — | -US$8.83M | — |
| 2025-03-31 | — | -US$4.58M | — |
| 2024-12-31 | — | -US$3.34M | — |
| 2024-09-30 | — | -US$17.46M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.